Thrombin Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017 - 2025

Thrombin Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017 - 2025

Jan 2018 Transparency Market Research Pharmaceutical162 Pages Price :
$ 5795

REPORT DESCRIPTION

Global Thrombin Market: Overview

This report on thrombin market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacturing and commercialization of thrombin products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global thrombin market with respect to the leading market segments based on major product segment, dosage form segment, and end users segment.

Global Thrombin Market: Key Segments

Based on the product type, the thrombin market has been segmented into bovine thrombin, human thrombin and recombinant thrombin. Each of the market segments have been extensively analyzed based on the market related factors such as increasing demand of thrombin products worldwide, and technological advancement. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the thrombin market and could influence the market in near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global thrombin market.

Global Thrombin Market: Regional Outlook

Geographically, thrombin market has been segmented into four major regions: North America, Europe, Asia Pacific, and Rest of World. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter’s five forces analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global thrombin market.

Companies Mentioned in Report

The report also profiles key players operating in the thrombin market which are Johnson & Johnson, Pfizer, Inc., Mallinckrodt Pharmaceuticals, Shanghai RAAS blood products co., Ltd., Japan Blood Products Organization and Mochida Pharmaceutical Co., Ltd.

The global thrombin market is segmented as follows:

Global Thrombin market, by Product

  • Bovine Thrombin
  • Human Thrombin
  • Recombinant Thrombin

Global Thrombin market, by Dosage Form

  • Powder Form
  • Solution Form
  • Others

 Global Thrombin market, by End User

  • Hospitals
  • Diagnostics Centers & Clinics
  • Academics and Research Institutes

Global Thrombin market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of the Europe
  • Asia Pacific
    • Japan
    • China
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Rest of World

Table of Content

1. Preface
1.1 Report Scope
1.2 Market Segmentation 
1.3 Research Highlights

2. Assumptions and Research Methodology
2.1 Assumptions
2.2 Acronyms Used
2.3 Research Methodology

3. Executive Summary

4. Market Overview
4.1 Product Overview
4.2 Key Industry Developments
4.3 Global Thrombin Market Size (US$ Mn) Forecast
4.4 Market Opportunity Map
4.5 Market Indicators
4.6 Porter’s Analysis 
4.7 Global Thrombin Market Outlook

5. Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Features of Ideal Hemostat at a glance
5.6 Key Brand Analysis
5.7 Regulatory Scenario 

6. Global Thrombin Market Analysis, by Product
6.1 Key Findings
6.2 Introduction
6.3 Global Thrombin Market Value Share Analysis, by Product
6.4 Global Thrombin Market Forecast, by Product
6.4.1. Bovine Thrombin
6.4.2. Human Thrombin
6.4.3. Recombinant Thrombin
6.5 Global Thrombin Market Analysis, by Product 
6.6 Global Thrombin Market Attractiveness Analysis, by Product

7. Global Thrombin Market Analysis, by Dosage Form
7.1 Key Findings
7.2 Introduction
7.3 Global Thrombin Market Value Share Analysis, by Dosage Form
7.4 Global Thrombin Market Forecast, by Dosage Form
7.4.1. Powder Forms
7.4.2. Solution Forms
7.4.3. Others
7.5 Global Thrombin Market Analysis, by Dosage Form
7.6 Global Thrombin Market Attractiveness Analysis, by Dosage Form

8. Global Thrombin Market Analysis, by End-user
8.1 Key Findings
8.2 Introduction
8.3 Global Thrombin Market Value Share Analysis, by End-user
8.4 Global Thrombin Market Forecast, by End-user
8.4.1. Hospitals
8.4.2. Diagnostics Centers & Clinics
8.4.3. Academics and Research Institutes
8.5 Global Thrombin Market Analysis, by End-user
8.6 Global Thrombin Market Attractiveness Analysis, by End-user

9. Thrombin Market Analysis, by Region
9.1 Global Thrombin Market Scenario
9.2 Introduction
9.3 Global Thrombin Market Value Share Analysis, by Region
9.3.1 North America
9.3.2 Europe
9.3.3 Asia Pacific
9.3.4 Rest of the World  
9.4 Global Thrombin Market Forecast, by Region
9.5 Global Thrombin Market Attractiveness Analysis, by Region

10. North America Thrombin Market Analysis
10.1 Key Findings
10.2 North America Thrombin Market Overview
10.3 North America Thrombin Market Value Share Analysis, by Country
10.4 North America Thrombin Market Forecast, by Country
10.4.1. U.S.
10.4.2. Canada
10.5 North America Thrombin Market Value Share Analysis, by Product
10.6 North America Thrombin Market Forecast, by Product
10.7 North America Thrombin Market Value Share Analysis, by Dosage Form
10.8 North America Thrombin Market Forecast, by Dosage Form
10.9 North America Thrombin Market Value Share Analysis, by End-user
10.10 North America Thrombin Market Forecast, by End-user
10.11 North America Thrombin Market Attractiveness Analysis

11. Europe Thrombin Market Analysis
11.1 Key Findings
11.2 Europe Thrombin Market Overview
11.3 Europe Thrombin Market Value Share Analysis, by Country
11.4 Europe Thrombin Market Forecast, by Country
11.4.1 Germany 
11.4.2 U.K.
11.4.3 France
11.4.4 Italy
11.4.5 Spain
11.4.6 Rest of the Europe
11.5 Europe Thrombin Market Value Share Analysis, by Product
11.6 Europe Thrombin Market Forecast, by Product
11.7 Europe Thrombin Market Value Share Analysis, by Dosage Form
11.8 Europe Thrombin Market Forecast, by Dosage Form
11.9 Europe Thrombin Market Value Share Analysis, by End-user
11.10 Europe Thrombin Market Forecast, by End-user
11.11 Europe Thrombin Market Attractiveness Analysis

12. Asia Pacific Thrombin Market Analysis
12.1 Key Findings
12.2 Asia Pacific Thrombin Market Overview
12.3 Asia Pacific Thrombin Market Value Share Analysis, by Country
12.4 Asia Pacific Thrombin Market Forecast, by Country
12.4.1 Japan
12.4.2 China 
12.4.3 Australia & New Zealand
12.4.4 Rest of Asia Pacific
12.5 Asia Pacific Thrombin Market Value Share Analysis, by Product
12.6 Asia Pacific Thrombin Market Forecast, by Product
12.7 Asia Pacific Thrombin Market Value Share Analysis, by Dosage Form
12.8 Asia Pacific Thrombin Market Forecast, by Dosage Form
12.9 Asia Pacific Thrombin Market Value Share Analysis, by End-user
12.10 Asia Pacific Thrombin Market Forecast, by End-user
12.11 Asia Pacific Thrombin Market Attractiveness Analysis

13. Rest of the World Thrombin Market Analysis
13.1 Key Findings
13.2 Rest of the World Thrombin Market Overview
13.3 Rest of the World Thrombin Market Value Share Analysis, by Country
13.5 Rest of the World Thrombin Market Value Share Analysis, by Product
13.6 Rest of the World Thrombin Market Forecast, by Product
13.7 Rest of the World Thrombin Market Value Share Analysis, by Dosage Form
13.8 Rest of the World Thrombin Market Forecast, by Dosage Form
13.9 Rest of the World Thrombin Market Value Share Analysis, by End-user
13.10 Rest of the World Thrombin Market Forecast, by End-user
13.11 Rest of the World Thrombin Market Attractiveness Analysis

14. Competition Landscape
14.1 Competition Matrix 
14.2 Thrombin Market: Heat Map Analysis by Company
14.3 Company Profiles
14.3.1 Johnson & Johnson Services, Inc.
14.3.1.1Company Details
14.3.1.1 Business Overview
14.3.1.2 Financial Overview
14.3.1.3 Strategic Overview
14.3.1.4 SWOT Analysis
14.3.2 Pfizer, Inc.
14.3.2.1 Company Details
14.3.2.2 Business Overview
14.3.2.3 Financial Overview
14.3.2.4 Strategic Overview
14.3.2.5 SWOT Analysis
14.3.3Mallinckrodt Pharmaceuticals
14.3.3.1 Company Details
14.3.3.2 Business Overview
14.3.3.3 Financial Overview
14.3.3.4 Strategic Overview
14.3.3.5 SWOT Analysis
14.3.4 Shanghai RAAS blood products co., Ltd.
14.3.4.1 Company Details
14.3.4.2 Business Overview
14.3.4.3 Financial Overview
14.3.4.4 Strategic Overview
14.3.4.5 SWOT Analysis
14.3.5 Japan Blood Products Organization
14.3.5.1 Company Details
14.3.5.2 Business Overview
14.3.5.3 Strategic Overview
14.3.5.4 SWOT Analysis
14.3.6 Mochida Pharmaceutical Co., Ltd. 
14.3.6.1 Company Details
14.3.6.2 Business Overview
14.3.6.3 Financial Overview
14.3.6.4 Strategic Overview
14.3.6.5 SWOT Analysis
14.3.7 BIOFAC A/S
14.3.7.1 Company Details
14.3.7.2 Business Overview
14.3.7.3 Strategic Overview
14.3.7.4 SWOT Analysis
14.3.8 Biomed-Lublin S.A.
14.3.8.1 Company Details
14.3.8.2 Business Overview
14.3.8.3 Financial Overview
14.3.8.4 Strategic Overview
14.3.8.5 SWOT Analysis
14.3.9 Hualan Biological Engineering, Inc.
14.3.9.1 Company Details
14.3.9.2 Business Overview
14.3.9.3 Strategic Overview
14.3.9.4 SWOT Analysis

List of Table

Table 01: Global Thrombin Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 02: Global Thrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025
Table 02: Global Thrombin Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 03: Global Thrombin Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 04: North America Thrombin Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 05: North America Thrombin Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 06: North America Thrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025
Table 07: North America Thrombin Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 08: Europe Thrombin Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 09: Europe Thrombin Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 10: Europe Thrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025
Table 11: Europe Thrombin Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 12: Asia Pacific Thrombin Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 13: Asia Pacific Thrombin Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 14: Asia Pacific Thrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025
Table 15: Asia Pacific Thrombin Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 16: Rest of the World Thrombin Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 17: Rest of the World Thrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025
Table 18: Rest of the World Thrombin Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 19: Johnson & Johnson Services, Inc.  Products & Services Offered
Table 20: Pfizer, Inc.  Business Overview
Table 21: Mallinckrodt Pharmaceuticals Business Overview
Table 22: Shanghai RAAS blood products co., Ltd. Business Overview
Table 23: Japan Blood Products Organization Business Overview
Table 24: Mochida Pharmaceutical Co., Ltd. Business Overview
Table 25: BIOFAC A/S Business Overview
Table 26: Biomed-Lublin S.A. Business Overview
Table 27: Hualan Biological Engineering, Inc. Business Overview

List of Chart

Figure 01: Global Thrombin Market Size (US$ Mn) Forecast, 2015–2025
Figure 02: Market Value Share, by Region (2016)
Figure 03: Market Value Share, by Product (2016)
Figure 04: Market Value Share, by Dosage Form (2016)
Figure 05: Market Value Share, by End User (2016)
Figure 06: Global Thrombin Market Value Share Analysis, by Product, 2016 and 2025
Figure 07: Global Thrombin Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Bovine Thrombin, 2015–2025
Figure 08: Global Thrombin Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Human Thrombin, 2015–2025
Figure 09: Global Thrombin Market Revenue (US$ Mn) and
Figure 10: Global Thrombin Market Attractiveness Analysis, by Product, 2017–2025
Figure 11: Global Thrombin Market Value Share, by Dosage Form, 2016 and 2025
Figure 12: Global Thrombin Market Revenue (US$ Mn), by Powder Form, 2015–2025
Figure 13: Global Thrombin Market Revenue (US$ Mn), by Solution Form, 2015–2025
Figure 14: Global Thrombin Market Revenue (US$ Mn), by Others, 2015–2025
Figure 15: Global Thrombin Market Attractiveness, by Dosage Form, 2015–2025
Figure 16: Global Thrombin Market Value Share Analysis, by End-user, 2016 and 2025
Figure 17: Global Thrombin Market Revenue (US$ Mn), by Human Source, 2015–2025
Figure 18: Global Thrombin Market Revenue (US$ Mn), by Diagnostic Centers & Clinics Source, 2015–2025
Figure 19: Global Thrombin Market Revenue (US$ Mn), by Academic and Research Institutes, 2015–2025
Figure 20: Global Thrombin Market Attractiveness Analysis, by End-user, 2015–2025
Figure 21: Global Thrombin Market Value Share Analysis, by Region, 2016 and 2025
Figure 22: Global Thrombin Market Attractiveness Analysis, by Region, 2015–2025 
Figure 23: North America Thrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 24: North America Thrombin Market Attractiveness Analysis, by Country, 2017–2025
Figure 25: North America Thrombin Market Value Share Analysis, by Country, 2016 and 2025
Figure 26: North America Thrombin Market Value Share Analysis, by Product, 2016 and 2025
Figure 27: North America Thrombin Market Value Share Analysis, by Dosage Form, 2016 and 2025
Figure 28: North America Thrombin Market Value Share Analysis, by End-user, 2016 and 2025
Figure 29: North America Thrombin Market Attractiveness Analysis, by Product,
Figure 30: North America Thrombin Market Attractiveness Analysis, by Dosage Form, 2017–2025
Figure 31: North America Thrombin Market Attractiveness Analysis, by End-user, 2017–2025
Figure 32: Europe Thrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 33: Europe Thrombin Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 34: Europe Thrombin Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 35: Europe Thrombin Market Value Share Analysis, by Product, 2016 and 2025
Figure 36: Europe Thrombin Market Value Share Analysis, by Dosage Form, 2016 and 2025
Figure 37: Europe Thrombin Market Value Share Analysis, by End-user, 2016 and 2025
Figure 38: Europe Thrombin Market Attractiveness Analysis, by Product,
Figure 39: Europe Thrombin Market Attractiveness Analysis, by Dosage Form, 2017–2025
Figure 40: Europe Thrombin Market Attractiveness Analysis, by End-user, 2017–2025
Figure 41: Asia Pacific Thrombin Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 42: Asia Pacific Thrombin Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 43: Asia Pacific Thrombin Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 44: Asia Pacific Thrombin Market Value Share Analysis, by Product, 2016 and 2025
Figure 45: Asia Pacific Thrombin Market Value Share Analysis, by Dosage Form, 2016 and 2025
Figure 46: Asia Pacific Thrombin Market Value Share Analysis, by End-user, 2016 and 2025
Figure 47: Asia Pacific Thrombin Market Attractiveness Analysis, by Product,
Figure 48: Asia Pacific Thrombin Market Attractiveness Analysis, by Dosage Form, 2017–2025
Figure 49: Asia Pacific Thrombin Market Attractiveness Analysis, by End-user, 2017–2025
Figure 50: Rest of the World Thrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 51: Rest of the World Thrombin Market Value Share Analysis, by Product, 2016 and 2025
Figure 52: Rest of the World Thrombin Market Value Share Analysis, by Dosage Form, 2016 and 2025
Figure 53: Rest of the World Thrombin Market Value Share Analysis, by End-user, 2016 and 2025
Figure 54: Rest of the World Thrombin Market Attractiveness Analysis, by Product,
Figure 55: Rest of the World Thrombin Market Attractiveness Analysis, by Dosage Form, 2017–2025
Figure 56: Rest of the World Thrombin Market Attractiveness Analysis, by End-user, 2017–2025
Figure 57: Thrombin Market: Heat Map Analysis by Company
Figure 58: Johnson & Johnson Services, Inc. Breakdown of Net Sales (US$ Mn)
Figure 59: Johnson & Johnson Services, Inc. R&D Intensity and Sales & Marketing Intensity (US$ Mn) - Company Level or Segment Level, 2015–2016
Figure 60: Johnson & Johnson Services, Inc. Breakdown of Net Sales, by Region, 2017
Figure 61: Johnson & Johnson Services, Inc. Breakdown of Net Sales, by Business Segment, 2017
Figure 62: Pfizer Inc. revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 63: Pfizer, Inc. R&D Intensity and Sales & Marketing Intensity (US$ Mn) - Company Level or Segment Level, 2015–2016
Figure 64: Pfizer, Inc. Breakdown of Net Sales (2016), by Region
Figure 65: Pfizer, Inc. Number of Discovery Projects till February 2016
Figure 66: Mallinckrodt Pharmaceuticals Breakdown of Net Sales, by Business Segment, 2016
Figure 67: Mallinckrodt Pharmaceuticals Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 68: Shanghai RAAS blood products co., Ltd. revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2015
Figure 69: Mochida Pharmaceutical Co., Ltd. revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 70: Biomed-Lublin S.A. revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2016
Figure 71: Global Thrombin Market Revenue Split, By Product (2016)
Figure 72: Global Thrombin Market Revenue Split, By Dosage Form (2016)
Figure 73: Global Thrombin Market Revenue Split, By Region (2016)

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Country :
  • Your Requirement
  • Security Code *
  • I agree to receive other communications from Market Research Hub, and allow Market Research Hub to store and process my personal data.*
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 5795
$ 8795

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top